1. Search Result
Search Result
Results for "

hemoglobinopathies

" in MCE Product Catalog:

4

Inhibitors & Agonists

1

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas
  • HY-139400
    (S)-Pociredir

    (S)-FTX-6058

    Histone Methyltransferase Cardiovascular Disease
    (S)-Pociredir ((S)-FTX-6058) is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). (S)-Pociredir can induce HbF protein expression in cell and murine models. (S)-Pociredir can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia.
  • HY-139400A
    (S)-Pociredir hydrochloride

    (S)-FTX-6058 hydrochloride

    Histone Methyltransferase Cardiovascular Disease
    (S)-Pociredir ((S)-FTX-6058) hydrochloride is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). (S)-Pociredir hydrochloride can induce HbF protein expression in cell and murine models. (S)-Pociredir hydrochloride can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia.
  • HY-139400B
    Pociredir

    FTX-6058

    Histone Methyltransferase Infection
    Pociredir (FTX-6058) is a potent, selective and orally active small-molecule inhibitor of embryonic ectoderm development (EED) with KD value of 0.163 nM. Pociredir can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease (SCD).
  • HY-Y1620
    3-(3,4-Dimethoxyphenyl)propanoic acid

    Others Cardiovascular Disease
    3-(3,4-Dimethoxyphenyl)propanoic acid is an orally active short-chain fatty acids (SCFAs). 3-(3,4-Dimethoxyphenyl)propanoic acid stimulates γ globin gene expression, erythropoiesis in vivo and is used for the β hemoglobinopathies and other anemias.